Legarde, Jessel P.

HRN: 21-45-69  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/08/2022
CEFTRIAXONE 1G (VIAL)
06/08/2022
06/15/2022
IVT
2grams
OD
PCAP-C
Waiting Final Action 
06/08/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/08/2022
06/15/2022
IVT
850mg
OD
PTB, PCAP-C
Waiting Final Action 
06/08/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/08/2022
06/15/2022
IVT
650mg
OD
PCAP C, PTB
Waiting Final Action 
06/10/2022
AZITHROMYCIN 500MG TABLET (TAB)
06/10/2022
06/14/2022
PO
500mg
Once A Day
PTB, PCAP C
Waiting Final Action 
06/10/2022
AZITHROMYCIN 500MG TABLET (TAB)
06/10/2022
06/14/2022
PO
500mg
Once A Day
PTB, PCAP C
Waiting Final Action 
06/10/2022
METRONIDAZOLE 500MG (TAB)
06/10/2022
06/17/2022
ORAL
500mg/tab
TID
AGE Sec To Amoebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: